Hardik Parikh

Stock Analyst at JP Morgan

(0.83)

# 2,824

Out of 4,479 analysts

2

Total ratings

50%

Success rate

-0.03%

Average return

Main Sectors:

Top Industries:

Biotechnology Drug Manufacturers - Specialty & Generic

2 Stocks

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	GPCR Structure Therapeutics	Initiates: Overweight	$65	$38.73	+67.83%	1	May 21, 2024
	PCRX Pacira BioSciences	Assumes: Overweight	$45	$22.74	+97.89%	1	Mar 7, 2024

Structure Therapeutics

May 21, 2024

Initiates: Overweight

Price Target: $65

Current: $38.73

Upside: +67.83%

Pacira BioSciences

Mar 7, 2024

Assumes: Overweight

Price Target: $45

Current: $22.74

Upside: +97.89%